Alzamend neuro announces completion of clinical portion of phase iia multiple ascending dose clinical trial for al001 treatment of dementia related to alzheimer's

Atlanta--(business wire)---- $acad #addf--alzamend neuro completes clinical portion of phase iia multiple ascending dose clinical trial for al001 treatment of dementia related to alzheimer's

ACAD Ratings Summary

ACAD Quant Ranking